Did Changing Sentiment Drive Micro-X's (ASX:MX1) Share Price Down A Painful 78%?

As every investor would know, not every swing hits the sweet spot. But really big losses can really drag down an overall portfolio. So take a moment to sympathize with the long term shareholders of Micro-X Limited (ASX:MX1), who have seen the share price tank a massive 78% over a three year period. That'd be enough to cause even the strongest minds some disquiet. And over the last year the share price fell 62%, so we doubt many shareholders are delighted. The falls have accelerated recently, with the share price down 48% in the last three months. Of course, this share price action may well have been influenced by the 35% decline in the broader market, throughout the period.

View our latest analysis for Micro-X

Given that Micro-X didn't make a profit in the last twelve months, we'll focus on revenue growth to form a quick view of its business development. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. As you can imagine, fast revenue growth, when maintained, often leads to fast profit growth.

In the last three years, Micro-X saw its revenue grow by 31% per year, compound. That is faster than most pre-profit companies. So why has the share priced crashed 39% per year, in the same time? You'd want to take a close look at the balance sheet, as well as the losses. Ultimately, revenue growth doesn't amount to much if the business can't scale well. Unless the balance sheet is strong, the company might have to raise capital.

The company's revenue and earnings (over time) are depicted in the image below (click to see the exact numbers).

ASX:MX1 Income Statement, March 24th 2020
ASX:MX1 Income Statement, March 24th 2020

This free interactive report on Micro-X's balance sheet strength is a great place to start, if you want to investigate the stock further.

Advertisement

A Different Perspective

The last twelve months weren't great for Micro-X shares, which performed worse than the market, costing holders 62%. The market shed around 25%, no doubt weighing on the stock price. Shareholders have lost 39% per year over the last three years, so the share price drop has become steeper, over the last year; a potential symptom of as yet unsolved challenges. Although Baron Rothschild famously said to "buy when there's blood in the streets, even if the blood is your own", he also focusses on high quality stocks with solid prospects. It's always interesting to track share price performance over the longer term. But to understand Micro-X better, we need to consider many other factors. Case in point: We've spotted 5 warning signs for Micro-X you should be aware of.

But note: Micro-X may not be the best stock to buy. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast).

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on AU exchanges.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.

M
mitchell_lawler
mitchell_lawler

When oil spikes, crude gets the attention. I think the boring refiner in the middle is where it gets interesting, and a record shows why.

56
Andrew Legget

Great earnings season, but are the earnings real?

Great earnings season, but are the earnings real? cover
At first glance, this was the strongest earnings season in years. But when you look at where the growth actually came from, the story splits into two very different pictures.
85

About ASX:MX1

Micro-X

Engages in the design, development, manufacturing, and commercialization of imaging products for healthcare and security markets through cold cathode X-ray technology in the United States, the Asia-Pacific, Europe, the Middle East, and Africa.

High growth potential and fair value.

Advertisement

Weekly Picks

LO
Lou_Basenese
ONCY logo
Lou_Basenese on Oncolytics Biotech ·

The Team Behind a $2 Billion Johnson & Johnson (JNJ) Deal Just Took Over This $105 Million Cancer Biotech

Fair Value:US$3.576.0% undervalued
46 users have followed this narrative
0 users have commented on this narrative
12 users have liked this narrative
AN
andrei9868
Emerging Author
NOW logo
andrei9868 on ServiceNow ·

The Platform Turning Enterprise Chaos into Autonomous Workflows

Fair Value:US$17015.9% undervalued
26 users have followed this narrative
2 users have commented on this narrative
5 users have liked this narrative
JO
John_Eric
Emerging Author
VST logo
John_Eric on Vistra ·

Vistra Fell 38%. Adjusted EBITDA Rose 31%. Here's the $472 Million Reason They Disagree.

Fair Value:US$291.8752.7% undervalued
13 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
HA
HarishPK
Emerging Author
EVER logo
HarishPK on EverQuote ·

EverQuote and an Asymmetric Investment Opportunity

Fair Value:US$36.0931.2% undervalued
6 users have followed this narrative
1 users have commented on this narrative
4 users have liked this narrative

Updated Narratives

TR
TripleS
SGMO.Q logo
TripleS on Sangamo Therapeutics ·

Likely recovery of 2.5X over the current stock price of Sangamo assuming milestone payments are successful

Fair Value:US$0.3654.4% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DE
Deep_Insights
HIMS logo
Deep_Insights on Hims & Hers Health ·

Hims & Hers Health Multidimensional Revenue Expansion

Fair Value:US$171.1983.4% undervalued
73 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
ST
StoxEurope
UCB logo
StoxEurope on UCB ·

FV 206,24 but with a 310-154 range...to discuss

Fair Value:€227.494.0% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28022.3% undervalued
375 users have followed this narrative
9 users have commented on this narrative
17 users have liked this narrative
JO
John_Eric
Emerging Author
MELI logo
John_Eric on MercadoLibre ·

MercadoLibre and the Spreadsheet Trick That Decides Everything

Fair Value:US$7.31k73.2% undervalued
128 users have followed this narrative
3 users have commented on this narrative
18 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.9119.3% overvalued
220 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative

Trending Discussion